rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4 Pt 1
|
pubmed:dateCreated |
1996-12-16
|
pubmed:abstractText |
In the present study we evaluated the effects of agents anticipated to change NO levels on the secretion of cholecystokinin (CCK) from STC-1 cells. After a 15-min treatment with the nitric oxide (NO) generating agent sodium nitroprusside (SNP; 10 microM), a 24% inhibition in basal CCK release and an increase in cellular guanosine 3',5'-cyclic monophosphate (cGMP) levels were noted. By contrast, SNP (10 microM) had no effect on CCK release stimulated by L-phenylalanine (20 mM). Inhibition of NO synthase (NOS) with NG-nitro-L-arginine methyl ester (L-NAME) produced dose-dependent stimulation in CCK release. L-NAME (100-400 microM) also inhibited ATP-sensitive potassium (KATP) channels in cell-attached patches. Pretreatment of cells with disopyramide (200 microM), a KATP channel blocker, blocked L-NAME stimulation of CCK release. After inhibition of potassium channel activity by L-NAME, addition of the nonhydrolyzable cGMP analogue 8-bromo-cGMP (1-2 mM) reactivated potassium channels. NO-generating agents had no effect on channel activity in inside-out membrane patches. It is concluded that NO may serve as an important regulator of basal CCK release.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channels,
http://linkedlifedata.com/resource/pubmed/chemical/Cholecystokinin,
http://linkedlifedata.com/resource/pubmed/chemical/Diltiazem,
http://linkedlifedata.com/resource/pubmed/chemical/Disopyramide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitroprusside,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channel Blockers,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0002-9513
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
271
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
G650-4
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8897884-Animals,
pubmed-meshheading:8897884-Calcium,
pubmed-meshheading:8897884-Calcium Channel Blockers,
pubmed-meshheading:8897884-Calcium Channels,
pubmed-meshheading:8897884-Cell Line,
pubmed-meshheading:8897884-Cells, Cultured,
pubmed-meshheading:8897884-Cholecystokinin,
pubmed-meshheading:8897884-Diltiazem,
pubmed-meshheading:8897884-Disopyramide,
pubmed-meshheading:8897884-Mice,
pubmed-meshheading:8897884-Nitric Oxide,
pubmed-meshheading:8897884-Nitroprusside,
pubmed-meshheading:8897884-Potassium,
pubmed-meshheading:8897884-Potassium Channel Blockers,
pubmed-meshheading:8897884-Potassium Channels
|
pubmed:year |
1996
|
pubmed:articleTitle |
Regulation of cholecystokinin secretion in STC-1 cells by nitric oxide.
|
pubmed:affiliation |
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|